Correlation Between Bristol-Myers Squibb and NAYA Biosciences,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and NAYA Biosciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and NAYA Biosciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and NAYA Biosciences,, you can compare the effects of market volatilities on Bristol-Myers Squibb and NAYA Biosciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of NAYA Biosciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and NAYA Biosciences,.

Diversification Opportunities for Bristol-Myers Squibb and NAYA Biosciences,

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bristol-Myers and NAYA is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and NAYA Biosciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NAYA Biosciences, and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with NAYA Biosciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NAYA Biosciences, has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and NAYA Biosciences, go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and NAYA Biosciences,

Assuming the 90 days horizon Bristol-Myers Squibb is expected to generate 2.13 times less return on investment than NAYA Biosciences,. But when comparing it to its historical volatility, Bristol Myers Squibb is 3.18 times less risky than NAYA Biosciences,. It trades about 0.04 of its potential returns per unit of risk. NAYA Biosciences, is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  149.00  in NAYA Biosciences, on September 2, 2024 and sell it today you would lose (51.00) from holding NAYA Biosciences, or give up 34.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy75.4%
ValuesDaily Returns

Bristol Myers Squibb  vs.  NAYA Biosciences,

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol-Myers Squibb reported solid returns over the last few months and may actually be approaching a breakup point.
NAYA Biosciences, 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in NAYA Biosciences, are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, NAYA Biosciences, sustained solid returns over the last few months and may actually be approaching a breakup point.

Bristol-Myers Squibb and NAYA Biosciences, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and NAYA Biosciences,

The main advantage of trading using opposite Bristol-Myers Squibb and NAYA Biosciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, NAYA Biosciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NAYA Biosciences, will offset losses from the drop in NAYA Biosciences,'s long position.
The idea behind Bristol Myers Squibb and NAYA Biosciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bonds Directory
Find actively traded corporate debentures issued by US companies